487
Views
12
CrossRef citations to date
0
Altmetric
Diabetes: Brief report

Glycemic control, reported pain and leakage with a 4 mm × 32 G pen needle in obese and non-obese adults with diabetes: a post hoc analysis

, , &
Pages 1305-1311 | Accepted 02 Jul 2012, Published online: 18 Jul 2012

References

  • De Coninck C, Frid A, Gaspar R, et al. Results and analysis of the 2008–2009 insulin injection technique questionnaire survey. J Diabetes 2010;2:168-79
  • Frid A, Linde B. Intraregional differences in the absorption of unmodified insulin from the abdominal wall. Diabet Med 1992;9:236-9
  • Schwartz S, Hassman D, Shelmet J, et al. A multicenter, open-label, randomized, two-period crossover trial comparing glycemic control, satisfaction, and preference achieved with a 31 gauge × 6mm needle versus a 29 gauge × 12.7mm needle in obese patients with diabetes mellitus. Clin Ther 2004;26:1663-78
  • Hirsch LJ, Klaff LJ, Bailey TS, et al. Comparative glycemic control, safety and patient ratings for a new 4 mm × 32G insulin pen needle in adults with diabetes. Curr Med Res Opin 2010;26:1531-41
  • Kreugel G, Keers JC, Kerstens MN, Wolffenbuttel BHR. Randomized trial on the influence of the length of two insulin pen needles on glycemic control and patient preference in obese patients with diabetes. Diab Tech Ther 2011;13:737-41
  • Ross SA, Jamal R, Leiter LA, et al. Evaluation of 8 mm insulin pen needles in people with type I and type 2 diabetes. Pract Diab Int 1999;16:145-8
  • Strauss K, Hannet I, McGonigle J, et al. Ultra-short (5 mm) insulin needles: trial results and clinical recommendations. Pract Diab Int 1999;16:218-22
  • Tubiana-Rufi N, Belarbi N, Du Pasquier-Fediaevsky L, et al. Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes. Diabetes Care 1999;22:1621-5
  • Frid A, Gunnarsson R, Guntner P, Linde B. Effects of accidental intramuscular injection on insulin absorption in IDDM. Diabetes Care 1988;11:41-5
  • Vaag A, Handberg AA, Laritzen M, et al. Variation in absorption of NPH insulin due to intramuscular injection. Diabetes Care 1990;13:74-6
  • Frid A, Ostman J, Linde B. Hypoglycemia risk during exercise after intramuscular injection of insulin in thigh in IDDM. Diabetes Care 1990;13:473-7
  • Karges B, Boehm BO, Karges W. Early hypoglycaemia after accidental intramuscular injection of insulin glargine. Diabet Med 2005;22:1444-5
  • Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin 2010;26:1519-30
  • Wittmann A, Kover J, Kralj N, et al. Insulin leakage value in relation to pen needle length and administered dose after subcutaneous injection. Diabetes Technol Ther 2010;12:587-90
  • Bijur PE, Silver W, Gallagher EJ. Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med 2001;8:1153-7
  • Powell CV, Kelly AM, Williams A. Determining the minimum clinically significant difference in visual analog pain score for children. Ann Emerg Med 2001;37:28-31

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.